Patrick Baeuerle

Founder, TCR2

Managing Director at MPM Capital

Munich, Bayern

About

Male

Patrick A. Baeuerle is the Executive Partner of MPM Capital. He previously worked at Amgen Research as a Vice President of Research and General Manager. Patrick A. Baeuerle attended the University of Konstanz and LMU Munich.

Experience

MPM Capital

Managing Director · 2015 – present

View →

31Boston, Massachusetts, United StatesBiotechnology · Health Care

MPM Capital

Excutive Partner · 2015 – present

View →

31Boston, Massachusetts, United StatesBiotechnology · Health Care

Board Member · TCR2
2015 – present
Board Member · Harpoon Therapeutics
2015 – present
Founder · Aktis Oncology
CSO & Co-Founder · Cullinan Therapeutics
Founder · TCR2

Education

Universitat Konstanz · B.Sc, Biochemie
1978 – 1987
Ludwig Maximilian University of Munich · Ph.D, Biology

Headlines from Google News. Social posts load from the platform only when you open a tab.

Merck brings Harpoon Therapeutics and its PhI/II T cell engager into the fold for $680M
Endpoints News · Jan 8
Aktis Oncology Announces $72M Series A Financing To Advance Breakthrough Radiopharmaceuticals To Treat Solid Tumors
PR Newswire · Mar 18
New Company Debuts with $72 Million to Advance a Novel Class of Targeted Radiopharmaceuticals
BioSpace · Mar 18
Novartis, Bristol Myers join $72M funding for startup’s cancer radiotherapy R&D
MedCity News · Mar 18
Aktis bags $72M in Novartis, BMS-backed series A to unlock power of radiopharmaceuticals
Fierce Biotech · Mar 18

People at MPM Capital

Elizabeth Stoner

Executive Partner

Ansbert Gadicke

Managing Director and Co-Founder

Data from: crunchbase